Kevin Y. Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment ...
Bowling Green WBKO on MSN
Med Center Health recognized for lung cancer care and biomarker testing
Biomarker testing helps identify effective targeted therapies and avoid those that are less likely to work in certain ...
In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...
Recognized in the Healthcare category of the 2025 Top Innovations contest, Haystack MRD® enables minimal residual disease ...
The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment ...
The race for early cancer detection is one that physicians have been running for millennia. In one of humanity’s oldest surviving medical texts, the ancient Egyptian physician Imhotep described 46 ...
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...
Processa Pharmaceuticals, Inc., a clinical-stage company specializing in next-generation cancer therapies, announced the acceptance of three abstracts for presentation at the 2025 American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback